fda approvals in msi-high cancers, priority reviews in gastric cancer and fl, and more
Published 7 years ago • 425 plays • Length 9:04
Download video MP4
Download video MP3
Similar videos
-
6:44
fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
8:51
fda approvals in prostate cancer and nsclc, priority review in aml, odac in all, and more
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
8:07
fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
-
5:17
msi testing’s impact on immunotherapy in gastric cancers
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
Clip.africa.com - Privacy-policy